Intravenous Gammaglobulin Treatment in HIV-1 Infection

Avi Deener, Ami Mehra, Larry Bernstein, Jenny Shliozberg, Arye Rubinstein

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The two main indications for the use of intravenous gammaglobulin-antibody replacement therapy and immunomodulation-are pertinent only for a few scenarios in HIV-1 infection. The role of gammaglobulin in the treatment of HIV-1 infection has changed significantly with the introduction of highly active antiretroviral therapy. Antiretroviral drugs have not only controlled the progression of disease but also had far-reaching effects on HIV-1-induced immunologic aberrations. Complete or partial immunologic reconstitution and prevention of immunologic damage have been the hallmarks of success for highly active antiretroviral therapy. This article addresses the use of gammaglobulin before and after the era of effective antiretroviral therapies.

Original languageEnglish (US)
Pages (from-to)851-859
Number of pages9
JournalImmunology and Allergy Clinics of North America
Volume28
Issue number4
DOIs
StatePublished - Nov 2008

Fingerprint

HIV Infections
HIV-1
Highly Active Antiretroviral Therapy
Immunomodulation
Intravenous Immunoglobulins
Disease Progression
Therapeutics
Pharmaceutical Preparations

Keywords

  • AIDS
  • B cells
  • Highly active antiretroviral therapy (HAART)
  • HIV-1
  • Immunodeficiency
  • Opportunistic infections
  • T cells
  • Thrombocytopenia

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Intravenous Gammaglobulin Treatment in HIV-1 Infection. / Deener, Avi; Mehra, Ami; Bernstein, Larry; Shliozberg, Jenny; Rubinstein, Arye.

In: Immunology and Allergy Clinics of North America, Vol. 28, No. 4, 11.2008, p. 851-859.

Research output: Contribution to journalArticle

Deener, Avi ; Mehra, Ami ; Bernstein, Larry ; Shliozberg, Jenny ; Rubinstein, Arye. / Intravenous Gammaglobulin Treatment in HIV-1 Infection. In: Immunology and Allergy Clinics of North America. 2008 ; Vol. 28, No. 4. pp. 851-859.
@article{8db1ea2a0f094a178517efdace6f2ec9,
title = "Intravenous Gammaglobulin Treatment in HIV-1 Infection",
abstract = "The two main indications for the use of intravenous gammaglobulin-antibody replacement therapy and immunomodulation-are pertinent only for a few scenarios in HIV-1 infection. The role of gammaglobulin in the treatment of HIV-1 infection has changed significantly with the introduction of highly active antiretroviral therapy. Antiretroviral drugs have not only controlled the progression of disease but also had far-reaching effects on HIV-1-induced immunologic aberrations. Complete or partial immunologic reconstitution and prevention of immunologic damage have been the hallmarks of success for highly active antiretroviral therapy. This article addresses the use of gammaglobulin before and after the era of effective antiretroviral therapies.",
keywords = "AIDS, B cells, Highly active antiretroviral therapy (HAART), HIV-1, Immunodeficiency, Opportunistic infections, T cells, Thrombocytopenia",
author = "Avi Deener and Ami Mehra and Larry Bernstein and Jenny Shliozberg and Arye Rubinstein",
year = "2008",
month = "11",
doi = "10.1016/j.iac.2008.06.001",
language = "English (US)",
volume = "28",
pages = "851--859",
journal = "Immunology and Allergy Clinics of North America",
issn = "0889-8561",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Intravenous Gammaglobulin Treatment in HIV-1 Infection

AU - Deener, Avi

AU - Mehra, Ami

AU - Bernstein, Larry

AU - Shliozberg, Jenny

AU - Rubinstein, Arye

PY - 2008/11

Y1 - 2008/11

N2 - The two main indications for the use of intravenous gammaglobulin-antibody replacement therapy and immunomodulation-are pertinent only for a few scenarios in HIV-1 infection. The role of gammaglobulin in the treatment of HIV-1 infection has changed significantly with the introduction of highly active antiretroviral therapy. Antiretroviral drugs have not only controlled the progression of disease but also had far-reaching effects on HIV-1-induced immunologic aberrations. Complete or partial immunologic reconstitution and prevention of immunologic damage have been the hallmarks of success for highly active antiretroviral therapy. This article addresses the use of gammaglobulin before and after the era of effective antiretroviral therapies.

AB - The two main indications for the use of intravenous gammaglobulin-antibody replacement therapy and immunomodulation-are pertinent only for a few scenarios in HIV-1 infection. The role of gammaglobulin in the treatment of HIV-1 infection has changed significantly with the introduction of highly active antiretroviral therapy. Antiretroviral drugs have not only controlled the progression of disease but also had far-reaching effects on HIV-1-induced immunologic aberrations. Complete or partial immunologic reconstitution and prevention of immunologic damage have been the hallmarks of success for highly active antiretroviral therapy. This article addresses the use of gammaglobulin before and after the era of effective antiretroviral therapies.

KW - AIDS

KW - B cells

KW - Highly active antiretroviral therapy (HAART)

KW - HIV-1

KW - Immunodeficiency

KW - Opportunistic infections

KW - T cells

KW - Thrombocytopenia

UR - http://www.scopus.com/inward/record.url?scp=53649095064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53649095064&partnerID=8YFLogxK

U2 - 10.1016/j.iac.2008.06.001

DO - 10.1016/j.iac.2008.06.001

M3 - Article

C2 - 18940578

AN - SCOPUS:53649095064

VL - 28

SP - 851

EP - 859

JO - Immunology and Allergy Clinics of North America

JF - Immunology and Allergy Clinics of North America

SN - 0889-8561

IS - 4

ER -